Theravance Biopharma, Inc. Annual Interest Expense in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Theravance Biopharma, Inc. quarterly/annual Interest Expense history and growth rate from 2014 to 2023.
  • Theravance Biopharma, Inc. Interest Expense for the quarter ending March 31, 2024 was $629K, a 14.4% increase year-over-year.
  • Theravance Biopharma, Inc. Interest Expense for the twelve months ending March 31, 2024 was $2.43M, a 49.2% decline year-over-year.
  • Theravance Biopharma, Inc. annual Interest Expense for 2023 was $2.35M, a 63.1% decline from 2022.
  • Theravance Biopharma, Inc. annual Interest Expense for 2022 was $6.37M, a 25.5% decline from 2021.
  • Theravance Biopharma, Inc. annual Interest Expense for 2021 was $8.55M, unchanged from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $2.35M -$4.02M -63.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-01
2022 $6.37M -$2.18M -25.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-01
2021 $8.55M $0 0% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-01
2020 $8.55M -$23.3M -73.2% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 $31.9M +$21.4M +204% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $10.5M +$1.94M +22.6% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-26
2017 $8.55M +$7.14M +509% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 $1.4M +$1.4M Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $0 $0 Jan 1, 2015 Dec 31, 2015 10-K 2018-02-28
2014 $0 Jan 1, 2014 Dec 31, 2014 10-K 2017-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.